Company intelligence
Kytopen
Open cells to new possibilities: Accelerating cell therapy processes from discovery through manufacturing with Flowfect®
About Kytopen
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect® platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect Discover™, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect Discover™ with the Flowfect Tx™ large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.
Verified activity
Signals from Kytopen
6 published signals
Presence & Recognition
Kytopen announced that John Zhao, Director of Process Development, is joining the All-Star Team for the Flowfect Tx Cell Engineering Grant.
Reported by Kytopen
Presence & Recognition
Kytopen is attending Advanced Therapies Europe to connect with others working across cell therapy.
Reported by Kytopen
Products & Services
Kytopen provides Flowfect Tx® RUO and GMP platforms to bring learnings into single-batch, continuous-flow processing at scale.
Reported by Kytopen
Products & Services
Kytopen provides Flowfect Discover™ platform to explore and optimize conditions in a 96-well format.
Reported by Kytopen
Presence & Recognition
Kytopen selected researchers to experience both Flowfect Discover™ and Flowfect Tx® Cell Engineering Training on a Tuesday.
Reported by Kytopen
People
Kytopen welcomed Conor McCarron, a third-generation Massachusetts native bringing 13 years of manufacturing and operations experience to the Flowfect Celled Engineering Experience.
Reported by Kytopen